Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial.
Vaccines (Basel)
; 11(8)2023 Aug 05.
Article
in En
| MEDLINE
| ID: mdl-37631897
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Vaccines (Basel)
Year:
2023
Document type:
Article
Affiliation country:
Tunisia
Country of publication:
Switzerland